Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Which Low Cost Index Funds For Retirement 2024 helps readers evaluate options based on fees, diversification, and suitability for retirement plans.
26,691 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
IBM shares have surged on AI optimism, prompting a disciplined look at entry points. This report analyzes a potential...
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Airbnb's path through 2026 to 2030 hinges on travel demand, new services, and pricing power. This report lays out sce...
After a staggering 453% surge, investors face a crossroads: take profits now or double down on a company reshaping th...
Vietnam and the Philippines have been upgraded to upper-middle-income status, signaling a new growth phase and bringi...
When dollar general stock dips, investors often worry about consumer weakness or policy shifts. This guide breaks dow...
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Dell shares rose about 6% to roughly $419 as AI infrastructure demand steadies, positioning the company as a leading ...
As China deepens ties with Iran, oil routes and market expectations shift. A veteran strategist highlights China’s gr...
Oracle plunges after earnings, amplifying a sell-off in cloud software as the company unveils a $40 billion capital r...
FuelCell Energy tumbles 10% as investors lock in gains in a sizzling sector, even as firms announce fresh deals and p...